Lazard Capital Downgrades MAKO Surgical (MAKO) to Hold
More News related to MAKO
- MAKO Surgical Corp. to Present at the 21st Annual Piper Jaffray Health Care Conference
- MAKO Surgical Corp. (MAKO) to Ring The NASDAQ Stock Market Opening Bell
- MAKO Surgical Corp. to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
- Mako Surgical (MAKO) Reports Q3 Loss of $0.33, Misses by 2c
- MAKO Surgical Corp. Reports Operating Results for the Third Quarter 2009
More News related to Downgrades
- Jefferies & Co Initiates Coverage Alpha Natural Resources (ANR) with a Buy
- BB&T Capital Initiates Coverage on Treehouse Foods (THS) with a Hold
- Morgan Joseph Initiates Coverage on St. Jude Medical (STJ) with a Buy; High-Quality Name in the Group
- Wells Fargo Resumes Coverage on Quest Diagnostics (DGX) with a Market Perform
- Piper Jaffray Initiates Coverage on Advisory Board Co. (ABCO) with an Overweight; Currently Trades at Discount
Lazard Capital downgrades MAKO Surgical (Nasdaq: MAKO) from Buy to Hold.
To see more analyst ratings on MAKO Click Here.
MAKO Surgical Corp., a medical device company, provides advanced robotic solution and orthopedic implants for minimally invasive orthopedic knee procedures.
Related Categories
DowngradesStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
